Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06383117 · ClinicalTrials.gov registry record · NA
Understanding Effects of Calcium on the Gut-Bone Axis
A NA study, sponsored by University of Georgia.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT06383117 is a NA study that has completed, run by University of Georgia. The registered enrollment target is 14 participants.
The verdict
NCT06383117, a NA study, has completed, sponsored by University of Georgia.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The study team is inviting 13 healthy people to complete a study to explore how calcium affects hormones and bones after eating. Participants will be asked to complete two study visits within eight weeks. Before each visit, participants will be asked to not eat or drink (except water) for 9 hours. At each visit, participants will eat the same meal provided by the research team. Along with their meal, they will take a pill - in one session, this will be a calcium supplement, and in the other, a placebo (a pill with no calcium), but they won't know which one they are taking at which session. A phlebotomist will draw blood before the meal and pill, then again several times after eating. Blood draws will take place over three hours. During that time, participants will complete questionnaires about health, diet, and physical activity. Blood will be analyzed to check on various health indicators, like bone health markers and certain hormones, to see how they change after the meal. The difference in these health indicators between the calcium and placebo sessions will help the study team understand the impact of calcium on health after eating. This could help increase knowledge of the impact of calcium on hormones and bone health.
Interventions
- DIETARY_SUPPLEMENT Placebo Control
- DIETARY_SUPPLEMENT Calcium carbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2023-10-17 |
| Est. Completion | 2024-02-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06383117
The ClinicalTrials.gov registry entry for NCT06383117 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Control is the first listed.
NCT06383117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06383117 about?
NCT06383117 is a clinical study titled "Understanding Effects of Calcium on the Gut-Bone Axis". The study team is inviting 13 healthy people to complete a study to explore how calcium affects hormones and bones after eating. Participants will be asked to complete two study visits within eight weeks. Before each visit, participants will be asked to not eat or drink (except water) for 9 hours. A...
What is the current status of trial NCT06383117?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2023-10-17. Estimated completion is 2024-02-23.
What interventions are being tested in trial NCT06383117?
The interventions under investigation include: Placebo Control (DIETARY_SUPPLEMENT), Calcium carbonate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06383117?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.